Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone

Janice Froehlich, Brett J. Hausauer, Dennis D. Rasmussen

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Background: Naltrexone (NTX) is underutilized in clinical treatment settings because its efficacy is modest, and it is not effective for all alcoholics and, when it is effective, a significant number of alcoholics fail to maintain initial treatment gains and subsequently relapse to heavy drinking. This has slowed acceptance of NTX by the treatment community, and there is a clear need for additional treatments for alcoholism and alcohol use disorders. Given that NTX and prazosin can each reduce alcohol drinking in rats selectively bred for alcohol preference and high voluntary alcohol drinking (alcohol-preferring "P" rats), we tested whether a combination of NTX + prazosin is more effective in decreasing alcohol drinking than is either drug alone. Methods: P rats were given access to a 15% (v/v) alcohol solution for 2 hours daily. Rats were fed NTX and prazosin, alone or in combination, prior to onset of the daily 2-hour alcohol access period for 4 weeks and the effect of drug treatment on alcohol and water intake was assessed. Results: During the first week of treatment, neither a low dose of NTX, nor prazosin, was effective in decreasing alcohol intake when each drug was administered alone, but combining the 2 drugs in a single medication significantly reduced alcohol intake. The combination was as effective as was a higher dose of NTX. Using a low dose of NTX in combination with prazosin may reduce the potential for undesirable side effects early in treatment which, in turn, may improve patient compliance and result in a more successful outcome when NTX is used for treating alcoholism and alcohol use disorders. Conclusions: Combining low-dose NTX and prazosin in a single medication may be more useful than is either drug alone for treating both inpatient and outpatient alcoholics and heavy drinkers early in the treatment process.

Original languageEnglish
Pages (from-to)1763-1770
Number of pages8
JournalAlcoholism: Clinical and Experimental Research
Volume37
Issue number10
DOIs
StatePublished - Oct 2013

Fingerprint

Naltrexone
Prazosin
Alcohol Drinking
Alcohols
Pharmaceutical Preparations
Alcoholics
Rats
Therapeutics
Alcoholism
Drinking
Drug therapy
Patient Compliance
Inpatients
Outpatients
Recurrence

Keywords

  • Alcoholism Treatment
  • Genetic Selection
  • Naltrexone
  • Prazosin

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Psychiatry and Mental health
  • Toxicology

Cite this

Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone. / Froehlich, Janice; Hausauer, Brett J.; Rasmussen, Dennis D.

In: Alcoholism: Clinical and Experimental Research, Vol. 37, No. 10, 10.2013, p. 1763-1770.

Research output: Contribution to journalArticle

@article{1d0a966e2190407bae2c3d15874c30b7,
title = "Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone",
abstract = "Background: Naltrexone (NTX) is underutilized in clinical treatment settings because its efficacy is modest, and it is not effective for all alcoholics and, when it is effective, a significant number of alcoholics fail to maintain initial treatment gains and subsequently relapse to heavy drinking. This has slowed acceptance of NTX by the treatment community, and there is a clear need for additional treatments for alcoholism and alcohol use disorders. Given that NTX and prazosin can each reduce alcohol drinking in rats selectively bred for alcohol preference and high voluntary alcohol drinking (alcohol-preferring {"}P{"} rats), we tested whether a combination of NTX + prazosin is more effective in decreasing alcohol drinking than is either drug alone. Methods: P rats were given access to a 15{\%} (v/v) alcohol solution for 2 hours daily. Rats were fed NTX and prazosin, alone or in combination, prior to onset of the daily 2-hour alcohol access period for 4 weeks and the effect of drug treatment on alcohol and water intake was assessed. Results: During the first week of treatment, neither a low dose of NTX, nor prazosin, was effective in decreasing alcohol intake when each drug was administered alone, but combining the 2 drugs in a single medication significantly reduced alcohol intake. The combination was as effective as was a higher dose of NTX. Using a low dose of NTX in combination with prazosin may reduce the potential for undesirable side effects early in treatment which, in turn, may improve patient compliance and result in a more successful outcome when NTX is used for treating alcoholism and alcohol use disorders. Conclusions: Combining low-dose NTX and prazosin in a single medication may be more useful than is either drug alone for treating both inpatient and outpatient alcoholics and heavy drinkers early in the treatment process.",
keywords = "Alcoholism Treatment, Genetic Selection, Naltrexone, Prazosin",
author = "Janice Froehlich and Hausauer, {Brett J.} and Rasmussen, {Dennis D.}",
year = "2013",
month = "10",
doi = "10.1111/acer.12148",
language = "English",
volume = "37",
pages = "1763--1770",
journal = "Alcoholism: Clinical and Experimental Research",
issn = "0145-6008",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - Combining naltrexone and prazosin in a single oral medication decreases alcohol drinking more effectively than does either drug alone

AU - Froehlich, Janice

AU - Hausauer, Brett J.

AU - Rasmussen, Dennis D.

PY - 2013/10

Y1 - 2013/10

N2 - Background: Naltrexone (NTX) is underutilized in clinical treatment settings because its efficacy is modest, and it is not effective for all alcoholics and, when it is effective, a significant number of alcoholics fail to maintain initial treatment gains and subsequently relapse to heavy drinking. This has slowed acceptance of NTX by the treatment community, and there is a clear need for additional treatments for alcoholism and alcohol use disorders. Given that NTX and prazosin can each reduce alcohol drinking in rats selectively bred for alcohol preference and high voluntary alcohol drinking (alcohol-preferring "P" rats), we tested whether a combination of NTX + prazosin is more effective in decreasing alcohol drinking than is either drug alone. Methods: P rats were given access to a 15% (v/v) alcohol solution for 2 hours daily. Rats were fed NTX and prazosin, alone or in combination, prior to onset of the daily 2-hour alcohol access period for 4 weeks and the effect of drug treatment on alcohol and water intake was assessed. Results: During the first week of treatment, neither a low dose of NTX, nor prazosin, was effective in decreasing alcohol intake when each drug was administered alone, but combining the 2 drugs in a single medication significantly reduced alcohol intake. The combination was as effective as was a higher dose of NTX. Using a low dose of NTX in combination with prazosin may reduce the potential for undesirable side effects early in treatment which, in turn, may improve patient compliance and result in a more successful outcome when NTX is used for treating alcoholism and alcohol use disorders. Conclusions: Combining low-dose NTX and prazosin in a single medication may be more useful than is either drug alone for treating both inpatient and outpatient alcoholics and heavy drinkers early in the treatment process.

AB - Background: Naltrexone (NTX) is underutilized in clinical treatment settings because its efficacy is modest, and it is not effective for all alcoholics and, when it is effective, a significant number of alcoholics fail to maintain initial treatment gains and subsequently relapse to heavy drinking. This has slowed acceptance of NTX by the treatment community, and there is a clear need for additional treatments for alcoholism and alcohol use disorders. Given that NTX and prazosin can each reduce alcohol drinking in rats selectively bred for alcohol preference and high voluntary alcohol drinking (alcohol-preferring "P" rats), we tested whether a combination of NTX + prazosin is more effective in decreasing alcohol drinking than is either drug alone. Methods: P rats were given access to a 15% (v/v) alcohol solution for 2 hours daily. Rats were fed NTX and prazosin, alone or in combination, prior to onset of the daily 2-hour alcohol access period for 4 weeks and the effect of drug treatment on alcohol and water intake was assessed. Results: During the first week of treatment, neither a low dose of NTX, nor prazosin, was effective in decreasing alcohol intake when each drug was administered alone, but combining the 2 drugs in a single medication significantly reduced alcohol intake. The combination was as effective as was a higher dose of NTX. Using a low dose of NTX in combination with prazosin may reduce the potential for undesirable side effects early in treatment which, in turn, may improve patient compliance and result in a more successful outcome when NTX is used for treating alcoholism and alcohol use disorders. Conclusions: Combining low-dose NTX and prazosin in a single medication may be more useful than is either drug alone for treating both inpatient and outpatient alcoholics and heavy drinkers early in the treatment process.

KW - Alcoholism Treatment

KW - Genetic Selection

KW - Naltrexone

KW - Prazosin

UR - http://www.scopus.com/inward/record.url?scp=84884983399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84884983399&partnerID=8YFLogxK

U2 - 10.1111/acer.12148

DO - 10.1111/acer.12148

M3 - Article

VL - 37

SP - 1763

EP - 1770

JO - Alcoholism: Clinical and Experimental Research

JF - Alcoholism: Clinical and Experimental Research

SN - 0145-6008

IS - 10

ER -